文献速递新发突发、热带与寄生虫病

恶性疟与间日疟AMA1入侵配体的功能保守性:加速疫苗与药物开发的新平台

Functional Conservation of the AMA1 Host-Cell Invasion Ligand Between P. falciparum and P. vivax: A Novel Platform to Accelerate Vaccine and Drug Development.
PubMed 文献 · J Infect Dis · 2018-01-01

研究通过基因替换在恶性疟原虫中表达间日疟AMA1,发现PvAMA1可互补PfAMA1功能并支持红细胞入侵;表达PvAMA1的虫株逃避抗PfAMA1抗体抑制,而抗重组PvAMA1抗体有效抑制入侵,表明AMA1功能保守但抗体具种属特异性。

要点

  • PvAMA1可替代PfAMA1支持恶性疟原虫入侵红细胞。
  • 抗PfAMA1抗体不能抑制表达PvAMA1的虫株入侵。
  • 抗重组PvAMA1抗体可有效抑制表达PvAMA1虫株的入侵。

核心结论

  • AMA1在恶性疟与间日疟间功能保守,尽管序列差异显著。

研究设计与样本

  • 在恶性疟原虫中基因替换PfAMA1为PvAMA1,并制备抗重组PvAMA1抗体进行入侵抑制实验。

主要发现

  • PvAMA1互补PfAMA1功能并支持恶性疟原虫入侵红细胞。
  • 表达PvAMA1的虫株逃避抗PfAMA1抗体的入侵抑制。
  • 抗重组PvAMA1抗体有效抑制表达PvAMA1虫株的入侵。

临床怎么用

  • 该平台可用于定量评估靶向PvAMA1的抗体或药物抑制活性。
  • 为间日疟疫苗与治疗药物开发提供新工具。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Plasmodium vivax and P. falciparum malaria species have diverged significantly in receptor-ligand interactions and host-cell invasion. One protein common to both is the merozoite invasion ligand AMA1. While the general structure of AMA1 is similar between species, their sequences are divergent. Surprisingly, it was possible to genetically replace PfAMA1 with PvAMA1 in P. falciparum parasites. PvAMA1 complemented PfAMA1 function and supported invasion of erythrocytes by P. falciparum. Genetically modified P. falciparum expressing PvAMA1 evaded the invasion inhibitory effects of antibodies to PfAMA1, demonstrating species specificity of functional antibodies. We generated antibodies to recombinant PvAMA1 that effectively inhibited invasion, confirming the function of PvAMA1 in genetically modified parasites. Results indicate significant molecular flexibility in AMA1 enabling conserved function despite substantial sequence divergence across species. This provides powerful new tools to quantify the inhibitory activities of antibodies or drugs targeting PvAMA1, opening new opportunities for vaccine and therapeutic development against P. vivax.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Drew DR, Sanders PR, Weiss G, et al. Functional Conservation of the AMA1 Host-Cell Invasion Ligand Between P. falciparum and P. vivax: A Novel Platform to Accelerate Vaccine and Drug Development. J Infect Dis. 2018. PMID: 29165651. doi:10.1093/infdis/jix583

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。